The rise of Artificial Intelligence (AI) has seen the technology being used in many applications and industries in today’s world. The latest industry to come onboard the AI train is in life sciences. Leading this adoption is none other than Knowledge Gate Group.
Knowledge Gate Group is an AI-powered platform that is connecting human intelligence to real world application. As the company puts it, “At Knowledge Gate Group, we exist to bridge the gap between businesses and life science experts. Connecting those looking to innovate with the key opinion leaders who can provide valuable insights. We have built our venture on our desire to democratize life science knowledge and drive operations forward that can ultimately lead to life-changing innovation.”
Users of the platform can access experts in a wide range of discipline including oncology, cell therapy, protein chemistry, immunology, biochemical engineering, endocrinology, cardiology, medical devices, regulatory affairs, nano-materials, clinical pharmacology, among a host of others.
The Knowledge Gate Group platform operates following three easy steps:
– Analysis: The tech analyzes clinical trials, academic articles, conferences, government reports, databases, and social media to automatically identify and rank key opinion leaders.
– Connection: The platform automatically reaches out and after passing a manual vetting, the selected experts are invited to be a part of the invitation-only platform.
– Interaction: The experts are then available for knowledge exchange session. Non-disclosure agreements, terms & conditions, and compliance requirements are taken care of and available on demand.
Through Knowledge Gate Group, academic researchers would be able to easily share their findings with companies working in the same field, which then leads to the quick development of solutions that can save lives. The platform can also help doctors in hospitals get second and even third opinions from specialists that are located halfway across the globe. Then there is the option of using the platform to ensure that investments are deployed to the right company by providing experts to review domain-specific due diligence that the investment company would have no oversight on otherwise.